Info

BloodStream

BloodStream is an entertaining and informational podcast for the bleeding disorders community. Each week, hemophilia patient Patrick James Lynch and former non-profit director Amy Board are joined by advocacy leaders, medical experts, and other guests to discuss the latest news, scientific advancements, policy initiatives, and so much more. Subscribe wherever you listen, or search BloodStream Podcast on YouTube to catch every episode there. Produced by Believe Limited. Presenting sponsor: Takeda.
RSS Feed
BloodStream
2024
April
March
February
January


2023
December
November
October
September
August
July
June
May
April
March
February
January


2022
December
November
October
September
August
July
June
May
April
March
February
January


2021
December
November
October
September
August
July
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
September
August
July
June
May
April
March
February
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
December
November
October
September
August
July
June
May
April
March
February
January


2016
December
November
October
September
August
July
June


Categories

All Episodes
Archives
Categories
Now displaying: Page 1
May 14, 2021

Patrick and Amy catch up on some recent community news then speak with leukemia survivor and bone marrow transplant recipient Bob Falkenberg as he’s set to kick off his 10th Lifeblood cycling ride to support Be The Match.

 

Notes:

PRESENTING SPONSOR: Takeda - bit.ly/TakedaBDsite

 

SUBSCRIBE to BloodStream on Apple Podcasts: bit.ly/BSPAP

CHECK OUT all our stuff:  bit.ly/AllBloodStreamStuff

 

BloodStream LIVE May 26th - Event link: http://bit.ly/BloodStreamIsBack

 

Bob’s Team Lifeblood: http://bihttps://bit.ly/3yaPj2U

NHF’s Community Voices in Research: http://bit.ly/CVRNHF

CSL and uniQure close agreement: http://bit.ly/CSLuni

Experimental SubQ Inhibitor Treatment: http://bit.ly/SubQinhib




0 Comments
Adding comments is not available at this time.